1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers
2025) In JCI Insight(
- Contribution to journal › Article
- 2024
-
Mark
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)
(
- Contribution to journal › Article
-
Mark
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)
(
- Contribution to journal › Article
-
Mark
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
(
- Contribution to journal › Article
- 2020
-
Mark
Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
(
- Contribution to journal › Article
-
Mark
Next Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes
(
- Contribution to journal › Article
- 2001
-
Mark
Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset
(
- Contribution to journal › Article